Ingo Eitel Arian Sultan Daniel Steven Holger Thiele Pavel Osmancik Julian Chun Boris Schmidt R. Saraei Thereby you surpassed the size of RENAL-AF - LAA-KIDNEY is the largest German RCT for AFib CKD 5!

🏆 Next milestone reached in LAA-KIDNEY trial

👏 Patient 1️⃣0️⃣0️⃣ successfully randomized by EP team Heart Center Cologne. Congratulations to Arian Sultan Daniel Steven

👉 classic.clinicaltrials.gov/ct2/show/NCT05…

Gunnar Henrik Heine Holger Thiele Pavel Osmancik Julian Chun Boris Schmidt R. Saraei

🫀 #TAVR lifetime management including the brand new DEDICATE DZHK6 data presented at 20th North German Heart Days

👉 DEDICATE: Another early win for #TAVI in low risk patients

👉 Lifetime management: The first cut is the deepest

Moritz Seiffert Holger Thiele DZHK Germany

☀️ Good morning from the 20th North German Heart Days Conference in Hamburg

👉 norddeutsche-herztage.de

🚢 Great location, faculty and lectures with cruise ships in the background

DZHK Germany Thomas Stiermaier Fabian Brunner Young DGK Christian-H. Heeger Tobias Schmidt

🫵🏼 Role of LAA underappreciated? Letz randomize more in RCT such as LAA kidney.

Ingo Eitel Roland Tilz AGEP Deutsche Gesellschaft für Kardiologie

You survived an infarct - what's your risk now? How's your heart going to cope with that injury?

We now can give a better answer to this question thanks to the analysis of the 3D morphology and contraction dynamics of the left ventricle. Details in link.springer.com/article/10.103…

Am 26. bis 27.04.24 finden die
20. Norddeutsche Herztage in Hamburg #Altona statt!

Wir freuen uns auf ihren Besuch an der Elbe!

✅Altes Fährterminal Altona
🙏Ingo Eitel Frank derck Marcus Dörr
S. Blankenberg P. Kirchhof

Roland Tilz Julia Vogler Shaojie Chen Evgeny Lyan

Presented today at #ACC24 :

A randomized trial that enrolled patients with severe aortic stenosis at low or intermediate surgical risk showed that TAVI was noninferior to SAVR at 1 year. Read the full DEDICATE-DZHK6 trial results: nej.md/3TLx8MT

🏆 Congratulations to Dominik Jurczyk and our #heartfailure #UHZL team for winning the poster award for CV Health Service Research at the 90th annual Deutsche Gesellschaft für Kardiologie conference

👉 Analysis of patient pathways in our Heart Failure Network North

Young-DZHK Young DGK Universitätsklinikum Schleswig-Holstein

Breaking🔥 STEP-HFpEF-DM 🔥

Semaglutide (vs placebo) leads to more weight loss, improved health status (KCCQ-CSS), increased walking distance, improved glycemic control, reduced inflammation (CRP), reduced natriuretic peptides, reduced HF hospitalizations, with favorable safety…

It took ~10 yrs to complete study enrollment in the DANGER SHOCK trial:
- among 360 pts with Cardiogenic shock complicating MI, Impella CP ⏬ mortality by 26% at 6-months
- NNT 8 pts
#ACC24 European Society of Cardiology SCAI Now
American College of Cardiology PCRonline 🫀 TCTMD Abiomed NEJM

DANGERSHOCK results presented at the ACC24 meeting - benefit of mechanical support of cardiogenic shock in myocardial infarction. Cardiac unloading works in cardiogenic shock and improves intermediate clinical outcomes! Full data in the NEJM.

AEGIS-II Trial
Negative results as already told:
♥️Apolipoprotein A1 infusion did NOT ⤵️ MI, Stroke or CV ☠️in AMI patients

Congratulations to C. Michael Gibson MD et al on this important trial

🚨🚨🚨Do we put HDL to bed?🚨🚨🚨
#ACC24

RelieveHF neutral, big interaction with regard to HF with reduced (benefit)vs preserved (harm)EF!!!
Much to think about
Interesting patient population with lower filling pressures at rest, very sick patient population Gregg W. Stone MD American College of Cardiology

RELIEVE HF trial #ACC24 #LBCT
🫀interatrial shunt in HF with any LVEF RCT: No difference in primary endpoint between the groups
🫀508 patients: randomized to device vs placebo: blinded!
🫀No difference in QOL but improved in both
🫀 did differ in HFrEF vs HFpEF: ⬆️ LVEF ⬆️harm

Successful Investigator and SC-Meeting for #CMRICDStudy at #DGKJahrestagung in #Mannheim ! 🤩Great to discuss the positive impact our research will have on patient care! Ingo Eitel DZHK Germany #AFNET #Afib #dzhk #mrt #cardiology #NIDCM #LVEF #MRI #deathrisk #ICDtherapy

Excellent poster presentation at the #DGKJahrestagung by our doctoral student Timo Rusack on his thesis, paving the way for novel targets in CAVD. Ingo Eitel Tobias Schmidt Thomas Stiermaier Tobias Graf

🤩University Kiel recruited #patient 900 in the #CLOSUREAFStudy ( #LAA closure vs. best medical care in patients with #NVAF at high risk of #stroke and bleeding). Thanks to all sites! #Afib DZHK Germany Ingo Eitel Matthias Lutz

Hope to see you all at the CMR-ICD Investigator Meeting at #DGKJahrestagung in #Mannheim .
April, 4 at 8:15 - Room: 10.
We are close to 250 randomized #patients !🎉
@DZHK Ingo Eitel #CMRICDStudy Manuela Licka Sergio Richter Daniel Steven Evgeny Lyan

📢Thyroid Function and outcomes in Takotsubo Syndrome. Our collaborative manuscript in eBioMedicine – The Lancet Discovery Science /Lancet (IF=11).
A cluster analysis with AI, from the European GEIST registry

📚🆓👉doi.org/10.1016/j.ebio…

Assem Aweimer Johannes W. Dietrich Holger Thiele
Ingo Eitel Luca Arcari